Showing results (211-220 of 634) with videos related to

Sort By:
Pageof 64
Plos One|June 24, 2017
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasmsFrancesco Panzuto, Noemi Cicchese, Stefano Partelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2024
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumoursPaola Mapelli, Carolina Bezzi, Francesca Muffatti, et al.
American Journal of Surgery|March 27, 2020
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3Elettra Merola, Massimo Falconi, Anja Rinke, et al.
Critical Reviews in Oncology/Hematology|December 15, 2015
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinomaNicola Silvestris, Vito Longo, Francesco Cellini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2023
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumorsPaola Mapelli, Carolina Bezzi, Francesca Muffatti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2023
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesionsGemma Rossi, Maria Chiara Petrone, Matteo Tacelli, et al.
JAMA Network Open|November 30, 2020
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous NeoplasmsGabriele Capurso, Stefano Crippa, Giuseppe Vanella, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2024
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancerGaetano Lauri, Laura Apadula, Livia Archibugi, et al.
Diagnostics (Basel, Switzerland)|February 2, 2021
Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine NeoplasmsPaola Mapelli, Stefano Partelli, Matteo Salgarello, et al.
Pageof 64